Daily Market Movement: Health Catalyst Inc (HCAT) Sees a -1.05 Decrease, Closing at 3.77

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

The closing price of Health Catalyst Inc (NASDAQ: HCAT) was $3.77 for the day, down -1.05% from the previous closing price of $3.81. In other words, the price has decreased by -$1.05 from its previous closing price. On the day, 0.53 million shares were traded. HCAT stock price reached its highest trading level at $3.93 during the session, while it also had its lowest trading level at $3.74.

Ratios:

Our analysis of HCAT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.24 and its Current Ratio is at 1.24. In the meantime, Its Debt-to-Equity ratio is 1.07 whereas as Long-Term Debt/Eq ratio is at 0.44.

KeyBanc Capital Markets Upgraded its Sector Weight to Overweight on January 08, 2025, while the target price for the stock was maintained at $9.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 05 ’25 when Landry Benjamin sold 6,057 shares for $3.94 per share. The transaction valued at 23,891 led to the insider holds 151,125 shares of the business.

BENJAMIN LANDRY bought 6,057 shares of HCAT for $23,925 on Jun 05 ’25. On Jun 02 ’25, another insider, Benjamin Landry, who serves as the Officer of the company, bought 3,255 shares for $3.63 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCAT now has a Market Capitalization of 265528640 and an Enterprise Value of 322793664. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.84 while its Price-to-Book (P/B) ratio in mrq is 0.70. Its current Enterprise Value per Revenue stands at 1.037 whereas that against EBITDA is -16.412.

Stock Price History:

The Beta on a monthly basis for HCAT is 1.52, which has changed by -0.3819672 over the last 52 weeks, in comparison to a change of 0.12632763 over the same period for the S&P500. Over the past 52 weeks, HCAT has reached a high of $9.24, while it has fallen to a 52-week low of $3.49. The 50-Day Moving Average of the stock is -3.86%, while the 200-Day Moving Average is calculated to be -36.55%.

Shares Statistics:

HCAT traded an average of 595.30K shares per day over the past three months and 687340 shares per day over the past ten days. A total of 69.48M shares are outstanding, with a floating share count of 66.17M. Insiders hold about 4.93% of the company’s shares, while institutions hold 79.76% stake in the company. Shares short for HCAT as of 1749772800 were 3237510 with a Short Ratio of 5.44, compared to 1747267200 on 3208167. Therefore, it implies a Short% of Shares Outstanding of 3237510 and a Short% of Float of 5.3100000000000005.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.